过去一年中添加的文章,按日期排序
Immunometabolic Mechanisms of LANCL2 in CD4+ T Cells and Phagocytes Provide Protection from Systemic Lupus Erythematosus
A Leber, R Hontecillas, N Tubau-Juni… - The Journal of …, 2024 - journals.aai.org
5 天前 - … lupus erythematosus (SLE) … + regulatory T cells compared with the wild type.
Conversely, treatment with NIM-1324 in the wild type increased CD25hi FOXP3+ regulatory T cells …
Conversely, treatment with NIM-1324 in the wild type increased CD25hi FOXP3+ regulatory T cells …
Jieduquyuziyin prescription alleviates lupus development via inhibiting neddylation pathway to promote Bim-induced apoptosis of double negative T cells
Y Li, Q Duan, C Wang, L Du, Z Jiang, S Li… - Journal of …, 2024 - Elsevier
7 天前 - Ethnopharmacological relevance Jieduquyuziyin prescription (JP) is an empirical
prescription approved for application to treat systemic lupus erythematosus (SLE) in hospital …
prescription approved for application to treat systemic lupus erythematosus (SLE) in hospital …
Identification of RNA uridylation subtypes, and the prognostic and therapeutic value of RNA uridylation in systemic lupus erythematosus
Y Zhang, H Yi, S Su, Z Ma, H Wu - International Immunopharmacology, 2024 - Elsevier
7 天前 - … Nonetheless, the role of TUTases in systemic lupus erythematosus (SLE) remains
unknown. Here we identified increased level of MTPAP and ZCCHC6 and decreased level of …
unknown. Here we identified increased level of MTPAP and ZCCHC6 and decreased level of …
Emerging Role and Mechanism of Mesenchymal Stem Cells-Derived Extracellular Vesicles in Rheumatic Disease
Z Wang, C Yang, S Yan, J Sun, J Zhang… - Journal of …, 2024 - Taylor & Francis
9 天前 - … are rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis
(… influence monocytes/macrophages, T cells, and B cells by producing bioactive factors …
(… influence monocytes/macrophages, T cells, and B cells by producing bioactive factors …
Immunopathogenesis of systemic lupus erythematosus: An update
L Arnaud, F Chasset, T Martin - Autoimmunity Reviews, 2024 - Elsevier
12 天前 - … Similarly, disturbances in T-cell compartments, altered regulatory T-cell
functions and altered cytokine production, particularly IFN-α, contribute to tissue damage. …
functions and altered cytokine production, particularly IFN-α, contribute to tissue damage. …
The Role of Prolactin as a Disease Activity Indicator in Some Rheumatic Diseases
MI Abdelkarem, HM Fayed… - … Journal of Medical …, 2024 - svuijm.journals.ekb.eg
12 天前 - … regulation. It controls the maturation of CD4-/CD8- thymocytes into mature CD4+/CD8+
T cells… between systemic lupus erythematosus activity and plasma levels of monomeric …
T cells… between systemic lupus erythematosus activity and plasma levels of monomeric …
Understanding Complex Chromatin Dynamics of Primary Human Neutrophils During PMA Induced NET Formation
B Atteberry, B Berman, T Kelly, J Cayford - Frontiers in Immunology - frontiersin.org
13 天前 - … This cell-death pathway is crucial for combating infections but is also implicated
in many inflammatory diseases such as sepsis, systemic lupus erythematosus, rheumatoid …
in many inflammatory diseases such as sepsis, systemic lupus erythematosus, rheumatoid …
Functional Characteristics of GPR56+ B Cell Subsets and Their Diagnostic Potential in Systemic Lupus Erythematosus
Z Xiong, Z Zong, A Bahabayi, J Chen, W Lin… - Available at SSRN … - papers.ssrn.com
13 天前 - … Objective: This study investigates the role of GPR56 in peripheral blood B cells and
its changes in systemic lupus erythematosus (SLE) patients, with an emphasis on its clinical …
its changes in systemic lupus erythematosus (SLE) patients, with an emphasis on its clinical …
[引用][C] Challenges and solutions for cellular therapy development in autoimmune diseases
ER Volkmann, J Varga, BR Blazar… - The Lancet …, 2024 - thelancet.com
15 天前 - … receptor (CAR) T cells targeting CD19 led to clinical improvement, remission, or
both, in patients with severe systemic lupus erythematosus, idiopathic inflammatory myositis, or …
both, in patients with severe systemic lupus erythematosus, idiopathic inflammatory myositis, or …
Application of novel CAR technologies to improve treatment of autoimmune disease
16 天前 - … T cells in treating severe B cell-mediated autoimmune diseases, like systemic lupus
erythematosus (… CAR T cells targeting autoreactive T cells are beginning clinical trials for …
erythematosus (… CAR T cells targeting autoreactive T cells are beginning clinical trials for …